Versant Venture Capital Vi, L.'s Net Worth
Versant Venture Capital Vi, L.'s net worth is estimated to be at least $69,510,489.64 as of 10/30/2025. CoreStreet's estimation of Versant Venture Capital Vi, L.'s net worth is based on their sale of stock and current holding of stock.
Versant Venture Capital Vi, L. is Major Shareholder at LAVA Therapeutics NV. They have executed at least 27 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,370,533 units of LVTX stock on 09/19/2025. Their biggest sale was on 10/18/2021 when they sold 550,000 units of Oyster Point Pharma Inc stock for $8,162,000.00. They typically trade 5 times per year.
Total value of insider buys:
- $33,892,599.68
Total value of insider sells:
- $35,617,889.96
Most recent insider trade:
- Sept. 19, 2025
Versant Venture Capital Vi, L.'s Insider Trading History
| LAVA Therapeutics NV | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 19, 2025 | Major Shareholder | 2,370,533 | $1.40 | Sell | $3,318,746.20 |
Sept. 18, 2025 | Major Shareholder | 366,111 | $1.44 | Sell | $527,199.84 |
Sept. 17, 2025 | Major Shareholder | 362,806 | $1.49 | Sell | $540,580.94 |
Sept. 16, 2025 | Major Shareholder | 307,707 | $1.53 | Sell | $470,791.71 |
| Monte Rosa Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 28, 2024 | Major Shareholder | 89,990 | $9.66 | Sell | $869,303.40 |
Sept. 20, 2024 | Major Shareholder | 1,132,566 | $6.53 | Sell | $7,395,655.98 |
Sept. 13, 2024 | Major Shareholder | 9,269 | $6.16 | Sell | $57,097.04 |
Sept. 11, 2024 | Major Shareholder | 541,897 | $6.00 | Sell | $3,251,382.00 |
| Tempest Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 12, 2024 | Major Shareholder | 387,999 | $1.10 | Sell | $426,798.90 |
Aug. 8, 2024 | Major Shareholder | 400,000 | $1.35 | Sell | $540,000.00 |
| Century Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 9, 2022 | Major Shareholder | 550,000 | $13.03 | Sell | $7,166,500.00 |
| Oyster Point Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 18, 2021 | Major Shareholder | 550,000 | $14.84 | Sell | $8,162,000.00 |
| Black Diamond Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 18, 2020 | Major Shareholder | 473 | $33.09 | Sell | $15,651.57 |
Nov. 16, 2020 | Major Shareholder | 177 | $33.01 | Sell | $5,842.77 |
Nov. 12, 2020 | Major Shareholder | 13,779 | $34.15 | Sell | $470,552.85 |
Nov. 9, 2020 | Major Shareholder | 5,565 | $33.06 | Sell | $183,978.90 |
Nov. 6, 2020 | Major Shareholder | 2,738 | $33.13 | Sell | $90,709.94 |
Nov. 4, 2020 | Major Shareholder | 2,208 | $33.14 | Sell | $73,173.12 |
Oct. 26, 2020 | Major Shareholder | 7,158 | $33.30 | Sell | $238,361.40 |
Oct. 19, 2020 | Major Shareholder | 3,739 | $33.43 | Sell | $124,994.77 |
Oct. 16, 2020 | Major Shareholder | 7,697 | $33.57 | Sell | $258,388.29 |
Oct. 14, 2020 | Major Shareholder | 4,859 | $33.09 | Sell | $160,784.31 |
Oct. 12, 2020 | Major Shareholder | 353 | $33.11 | Sell | $11,687.83 |
Oct. 8, 2020 | Major Shareholder | 16,276 | $33.47 | Sell | $544,757.72 |
Oct. 6, 2020 | Major Shareholder | 15,980 | $33.26 | Sell | $531,494.80 |
Aug. 10, 2020 | Major Shareholder | 5,492 | $33.04 | Sell | $181,455.68 |
Feb. 3, 2020 | Major Shareholder | 894,736 | $37.88 | Buy | $33,892,599.68 |